PS-002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PS-002, covering 2026-03-20 to 2026-03-20. Get the full timeline:
Most recent: Clinical Trial Update: PS-002 for the Treatment of IgA Nephropathy in Adults [Phase 1, Phase 2]